Breaking Finance News

Integer Holdings ITGR (NYSE:ITGR) has been downgraded from Buy to Neutral in a statement by Northcoast Research earlier today.

Having a price of $51.75, Integer Holdings ITGR (NYSE:ITGR) traded -3.15% lower on the day. With the last close up 19.61% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.03% over the same period. ITGR has recorded a 50-day average of $50.39 and a two hundred day average of $43.97. Trade Volume was down over the average, with 90,665 shares of ITGR changing hands under the typical 162,200

Northcoast Research has downgraded Integer Holdings ITGR (NYSE:ITGR) from Buy to Neutral in a statement released on Monday October 23, 2017.

On 4/24/2017, RBC Capital Markets released a statement on Integer Holdings ITGR (NYSE:ITGR) upped the target price from $0.00 to $35.00 that suggested a downside of -0.03%.

Recent Performance Chart

Integer Holdings ITGR (NYSE:ITGR)

Integer Holdings ITGR has PE ratio of 90.36 with a one year low of $18.10 and a one year high of $55.20 and has a market capitalization of $0.

General Company Details For Integer Holdings ITGR (NYSE:ITGR)

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products. It also provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems. In addition, the company provides products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products. Further, it offers cardiac and neuromodulation products, such as batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures; pacemakers, implantable cardiac defibrillators, cardiac resynchronization therapy devices, implantable cardiac monitors, and other implantable devices; and neuromodulation medical devices. Additionally, it offers customized battery power and management systems, charging and docking stations, and power supplies for energy, military, and environmental markets. It serves cardiac, neuromodulation, orthopedics, vascular, and advanced surgical markets, as well as multi-national original equipment manufacturers and their affiliated subsidiaries. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Frisco, Texas.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.